BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 30945628)

  • 21. Diabetic nephropathy in patients with type 1 diabetes mellitus.
    Russell TA
    Nephrol Nurs J; 2006; 33(1):15-28; quiz 29-30. PubMed ID: 16538925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting, managing and preventing new-onset diabetes after transplantation.
    Gosmanov AR; Dagogo-Jack S
    Minerva Endocrinol; 2012 Sep; 37(3):233-46. PubMed ID: 22766890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreas transplantation for the prevention of diabetic nephropathy.
    Stegall MD; Larson TS; Kudva YC; Grande JP; Nyberg SL; Prieto M; Velosa JA; Rizza RA
    Mayo Clin Proc; 2000 Jan; 75(1):49-56. PubMed ID: 10630757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in early biomarkers of diabetic nephropathy.
    Zhang J; Liu J; Qin X
    Rev Assoc Med Bras (1992); 2018 Jan; 64(1):85-92. PubMed ID: 29561946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Diabetes Knowledge Among Renal Transplant Recipients With Posttransplant Diabetes Mellitus: Kuwait Experience.
    Othman N; Gheith O; Al-Otaibi T; Mahmoud T; Al-Refaei F; Mahmoud F; Abduo H; Nampoory N; Halim MA; Najeb A
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):277-285. PubMed ID: 30777574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetic nephropathy--the family physician's role.
    Roett MA; Liegl S; Jabbarpour Y
    Am Fam Physician; 2012 May; 85(9):883-9. PubMed ID: 22612183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diabetes mellitus after renal transplant].
    Ruas L; Bastos M; Alves R; Gomes H; Rodrigues D; Barros L; Mota A; Carvalheiro M; Furtado AR
    Acta Med Port; 1996; 9(7-9):233-5. PubMed ID: 9005702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy.
    Rashid RM; Nabi Z; Ansari AZ; Qaiser QA
    BMC Nephrol; 2018 Mar; 19(1):69. PubMed ID: 29554892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal replacement therapy in patients with diabetic nephropathy, 1980-1985. Report from the European Dialysis and Transplant Association Registry.
    Brunner FP; Brynger H; Challah S; Fassbinder W; Geerlings W; Selwood NH; Tufveson G; Wing AJ
    Nephrol Dial Transplant; 1988; 3(5):585-95. PubMed ID: 3146713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early diabetic nephropathy. Emerging treatment options.
    Carella MJ; Gossain VV; Rovner DR
    Arch Intern Med; 1994 Mar; 154(6):625-30. PubMed ID: 8129495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management.
    First MR; Gerber DA; Hariharan S; Kaufman DB; Shapiro R
    Transplantation; 2002 Feb; 73(3):379-86. PubMed ID: 11884934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of ACE and AT-2 inhibitors on mortality and progression to microalbuminuria in a nested case-control study of diabetic nephropathy in diabetes mellitus type 2: results from the GENDIAN study.
    Böger CA; Haak T; Götz AK; Christ J; Ruff E; Hoffmann U; Riegger GA; Krämer BK
    Int J Clin Pharmacol Ther; 2006 Aug; 44(8):364-74. PubMed ID: 16961167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current issues in the diagnosis and therapy of diabetic nephropathy].
    de Châtel R; Mogyorósi A; Ziyadeh FN
    Orv Hetil; 1997 Jan; 138(4):187-93. PubMed ID: 9072751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining kidney allograft benefit from successful pancreas transplant: separating fact from fiction.
    Wiseman AC; Stites E; Kennealey P
    Curr Opin Organ Transplant; 2018 Aug; 23(4):448-453. PubMed ID: 29878910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diabetes mellitus, hypertension and kidney].
    Monhart V
    Vnitr Lek; 2008 May; 54(5):499-504, 507. PubMed ID: 18630636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current concepts in the management of diabetic nephropathy.
    Waanders F; Visser FW; Gans RO
    Neth J Med; 2013 Nov; 71(9):448-58. PubMed ID: 24218418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk Factors of Recurrence of Diabetic Nephropathy in Renal Transplants.
    Rodriguez Cubillo B; Rodriguez B; Calvo M; de la Manzanara V; Bautista J; Perez-Flores I; Calvo N; Moreno A; Shabaka A; Delgado J; Sanchez-Fructuoso AI
    Transplant Proc; 2016 Nov; 48(9):2956-2958. PubMed ID: 27932117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment.
    Ayodele OE; Alebiosu CO; Salako BL
    J Natl Med Assoc; 2004 Nov; 96(11):1445-54. PubMed ID: 15586648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for the development of new-onset diabetes mellitus in a living related renal transplant program.
    Bora GS; Guleria S; Reddy VS; Tandon N; Gupta N; Gupta S; Bhowmik D
    Transplant Proc; 2010 Dec; 42(10):4072-3. PubMed ID: 21168630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.